Alliance for Pharmacy Compounding

When FDA-approved drugs are in shortage, patients still need their medications. Compounded medications are a lifeline when the regular drug supply chain fails patients, but the so-called SAFE Drugs Act proposes severely limiting this, putting patients at risk. Tell your senator to protect shortage-drug compounding: https://hubs.la/Q04pQP2M0.

Got hormone therapy knowledge but not sure how to turn it into a thriving service? 📈

EduCon kicks off August 6 with "Designing a Hormone Consult Practice That Works," featuring Melinda Fowler, RPh (The Hormonal Pharmacist). She’ll share real-world strategies to help you launch a private, long-term consulting practice.

This year’s 6-part clinical CE series is all about hormones—and it’s perfect for pharmacy technicians, too! One registration gets you all 6 hours, live or on-demand.

🔗 Register today at https://hubs.la/Q04p52qP0

Former U.S. Surgeon General Dr. Jerome Adams is calling on the FDA to chart a "third way" on peptides—allowing licensed compounding pharmacies to provide them under strict quality standards rather than forcing a blanket ban. 🤝

Writing in STAT News, Dr. Adams highlights the upcoming July 23-24 PCAC meeting as the perfect moment for the FDA to protect patients and support clinician-guided care.

This validates what APC has been saying about a middle path on peptides, and we’ll be sharing our more detailed perspective in comments to FDA. In the meantime, give Dr. Adams’ column a look.

🔗 https://hubs.la/Q04nR1fP0